ACT Capital Management, LLC
- SEC CIK
- 0001442273
- Latest filing
- Jul 29, 2026
KRYS holding history
Krystal Biotech, Inc. in every 13F filed by ACT Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KRYS overviewAll 13F holders of KRYSFull Q2 2026 holdings
- Shares (Q2 2026)
- 45,000
- Value
- $16.7M
- % of portfolio
- 10.9%
- Quarters held
- 9
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 45,000 | $16.7M | 10.9% | −15,477−25.6% | Reduced | Holders |
| Q1 2026 | 60,477 | $15.6M | 12.3% | −230.0% | Reduced | Holders |
| Q4 2025 | 60,500 | $14.9M | 12.1% | – | No prior filing | Holders |
| Q4 2022 | – | – | – | – | Not filed | Holders |
| Q3 2022 | 58,300 | $4.06M | 5.6% | −700−1.2% | Reduced | Holders |
| Q2 2022 | 59,000 | $3.87M | 5.4% | 00.0% | Unchanged | Holders |
| Q1 2022 | 59,000 | $3.93M | 4.2% | 00.0% | Unchanged | Holders |
| Q4 2021 | 59,000 | $4.13M | 3.0% | +19,000+47.5% | Added | Holders |
| Q3 2021 | 40,000 | $2.09M | 1.1% | +20,925+109.7% | Added | Holders |
| Q2 2021 | 19,075 | $1.30M | 0.7% | – | No prior filing | Holders |